Investor Overview

Update

Bio One Capital Pte Ltd, a subsidiary of EDB Investments (EDBI), is dedicated to investments in the Biomedical Sciences industry.

Description

Update

Bio One Capital Pte Ltd, a subsidiary of EDB Investments (EDBI), is dedicated to investments in the Biomedical Sciences industry. Biomedical Sciences (BMS) is a key economic driver and an important pillar of Singapore's diverse economy. With over US$790 million currently under management, Bio*One Capital is actively investing their fourth fund, Biomedical Sciences Investments Fund (BMSIF). Key sectors of interest are therapeutics and therapeutics services, medical technology and healthcare services.

Investments (16)

Update